The giant anteater (Myrmecophaga tridactyla) is one of the three species in the family Myrmecophagidae of the suborder Vermilingua. It is the only species of the genus Myrmecophaga. The species, subject to increasing threats in its natural environment, is classified as vulnerable on the International Union for the Conservation of Nature Red List of Threatened Species. European zoos are involved in the ex situ conservation of the giant anteater, which is essential for its long-term viability. However, the diseases encountered by European captive populations of giant anteaters are not well documented, and best practice guidelines are not yet available for the species. An online two-part survey was conducted among European institutions hosting or having housed anteaters over a 20-yr period concerning the current management of captive populations and the diseases encountered. Medical data were collected from 99 giant anteaters from 30 institutions. Among the study population, 4% of the individuals were born in the wild and 96% were born in captivity. Seventy animals (71%) were still alive at the time of data collection, with an average age of 8 yr. A predominance of digestive (20%), dermatologic (20%)-with mainly wounds-and internal parasitism (18%) disorders was observed, followed by behavioral (13%), musculoskeletal (12%), respiratory (11%), nutritional (10%), and ocular (9%) disorders. Mortality mainly concerns the most extreme age categories: very young individuals, mostly secondary to trauma, and older individuals with no main cause identified. This paper details all the medical conditions reported in the European captive giant anteaters included in the study. It allows us to formulate some medical and zootechnical recommendations for the species management and to envisage new research perspectives.